.
BioEnterprise

Myomo Plans to Go Public Without Wall Street

Myomo, a Boston-based medical robotics maker with manufacturing from Cleveland-based Geauga Rehabilitation Engineering, is the first Reg A+ offering poised for the New York Stock Exchange. Reg A+ is a provision of the Jumpstart Our Business Startups Act designed to help fund small-business growth by removing some hurdles for companies trying to go public.

Read More  >
Hello. Add your message here.